Apollo Hospitals Enterprise Limited appears to be a financially healthy company, with strengths in earnings growth (53.5%) and decent revenue growth (13.1%). However, the company's valuation seems stretched, with a trailing P/E of 69.43 and forward P/E of 85.86, indicating that the stock may be overpriced. A weakness lies in the company's high debt-to-equity ratio of 90.89, which may pose a risk to its financial stability. Despite this, the company's profitability metrics, such as ROE and profit margins, are respectable. Overall, the company's financial health is good, but investors should exercise caution due to the high valuation and debt levels.